PriCoTTF: A phase I/II single-arm trial of tumor treating fields prior and concomitant with radiotherapy and temozolomide in newly diagnosed glioblastoma

被引：0
|
作者：
Glas, M. [1 ]
Scheffler, B. [2 ]
Lazaridis, L. [1 ]
Herrlinger, U. [3 ]
Pierscianek, D. [4 ]
El Hindy, N. [4 ]
Sure, U. [4 ]
Proescholdt, M. [5 ]
Hau, P. [6 ]
Hense, J. [7 ]
Kleinschnitz, C. [8 ]
Combs, S. E. [9 ]
Grosu, A. -L. [10 ]
Stuschke, M. [11 ]
Kebir, S. [1 ]
机构：
[1] Univ Klinikum Essen, Klin Neuroonkol, Essen, Germany
[2] Univ Klinikum Essen, Translat Onkol, Westdeutsch Tumorzentrum, Essen, Germany
[3] Univ Klinikum Bonn, Klin Neuroonkol, Bonn, Germany
[4] Univ Klinikum Essen, Klin Neurochirurg, Essen, Germany
[5] Univ Klinikum Regensburg, Neurochirurg, Regensburg, Germany
[6] Univ Klinikum Regensburg, Neurol NeuroOnkol, Regensburg, Germany
[7] Univ Klinikum Essen, Innere Klin Tumorforsch, Essen, Germany
[8] Univ Klinikum Essen, Neurol Klin, Essen, Germany
[9] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin RadioOnkol & Strahlentherapie, Munich, Germany
[10] Univ Klinikum Freiburg, Klin Strahlenheilkunde, Freiburg, Germany
[11] Univ Klinikum Essen, Klin Strahlenheilkunde, Essen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2018年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P02-5
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [31] Tumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center
    Chen, Chunjui
    Xu, Hao
    Song, Kun
    Zhang, Yi
    Zhang, Junyan
    Wang, Yang
    Sheng, Xiaofang
    Chen, Lingchao
    Qin, Zhiyong
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [32] Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
    Ishikawa, Eiichi
    Muragaki, Yoshihiro
    Yamamoto, Tetsuya
    Maruyama, Takashi
    Tsuboi, Koji
    Ikuta, Soko
    Hashimoto, Koichi
    Uemae, Youji
    Ishihara, Takeshi
    Matsuda, Masahide
    Matsutani, Masao
    Karasawa, Katsuyuki
    Nakazato, Yoichi
    Abe, Tatsuya
    Ohno, Tadao
    Matsumura, Akira
    JOURNAL OF NEUROSURGERY, 2014, 121 (03) : 543 - 553
  • [33] Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
    Stupp, Roger
    Hegi, Monika E.
    Neyns, Bart
    Goldbrunner, Roland
    Schlegel, Uwe
    Clement, Paul M. J.
    Grabenbauer, Gerhard G.
    Ochsenbein, Adrian F.
    Simon, Matthias
    Dietrich, Pierre-Yves
    Pietsch, Torsten
    Hicking, Christine
    Tonn, Joerg-Christian
    Diserens, Annie-Claire
    Pica, Alessia
    Hermisson, Mirjam
    Krueger, Stefan
    Picard, Martin
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2712 - 2718
  • [34] Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma
    Biau, J.
    Thivat, E.
    Chautard, E.
    Stefan, D.
    Boone, M.
    Chauffert, B.
    Bourgne, C.
    Richard, D.
    Molnar, I
    Levesque, S.
    Bellini, R.
    Kwiatkowski, F.
    Karayan-Tapon, L.
    Verrelle, P.
    Godfraind, C.
    Durando, X.
    RADIOTHERAPY AND ONCOLOGY, 2021, 154 : 227 - 234
  • [35] Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma
    Ciesielski, Michael J.
    Ahluwalia, Manmeet Singh
    Reardon, David A.
    Abad, Ajay P.
    Curry, William T.
    Wong, Eric T.
    Peereboom, David M.
    Figel, Sheila A.
    Hutson, Alan
    Groman, Adrienne
    Withers, Henry G.
    Liu, Song
    Belal, Ahmed
    Qiu, Jing-Xin
    Mogensen, Kathleen
    Schilero, Cathy
    Casucci, Danielle M.
    Mechtler, Laszlo
    Fenstermaker, Robert Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] TUMOR TREATING FIELDS COMBINE WITH TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA: A RETROSPECTIVE ANALYSIS OF CHINESE PATIENTS
    Qin, Zhiyong
    Chen, Lingchao
    Chen, Junrui
    Yao, Yu
    Wu, Jinsong
    Zhuang, Dongxiao
    Nie, Jigntao
    NEURO-ONCOLOGY, 2022, 24 : 82 - 82
  • [37] SPARE TRIAL: SCALP-SPARING RADIATION WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Miller, Ryan
    Song, Andrew
    Ali, Ayesha S.
    Bar-Ad, Voichita
    Martinez, L.
    Glass, Jon
    Alnahhas, Iyad
    Andrews, David
    Judy, Kevin
    Evans, James
    Farrell, Christopher
    Werner-Wasik, Maria
    Chervoneva, Inna
    Ly, May
    Palmer, Joshua
    Liu, Haisong
    Shi, Wenyin
    NEURO-ONCOLOGY, 2021, 23 : 43 - 44
  • [38] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
  • [39] Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
    Lai, Shuzhen
    Li, Peijing
    Liu, Xiaohui
    Liu, Guihong
    Xie, Tieming
    Zhang, Xing
    Wang, Xiaoxuan
    Huang, Jing
    Tang, Yiqiang
    Liu, Zhigang
    Shen, Guoping
    Li, Chaoming
    Lu, Fangxiao
    Wang, Lei
    Jiang, Fagui
    Sun, Caixing
    Chen, Yuanyuan
    Chen, Ming
    CANCER BIOLOGY & MEDICINE, 2024, 21 (05)
  • [40] Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial
    Ji, Nan
    Zhang, Yang
    Liu, Yunpeng
    Xie, Jian
    Wang, Yi
    Hao, Shuyu
    Gao, Zhixian
    JCI INSIGHT, 2018, 3 (10):
12345